
































Autophagy is an evolutionarily conserved cellular 
turnover process that maintains cellular and energetic 
homeostasis [1, 2] by eliminating unwanted cytoplasmic 
debris, for instance aged or dysfunctional organelles and 
proteins [3]. Two additional lysosomal degradation 
mechanisms have been characterized in mammalian 
systems, chaperone-mediated autophagy (CMA) [4] and 
microautophagy [5]. Although all forms of autophagy 
function to deliver cytoplasmic substrates into 
lysosomes, these forms are distinct in their molecular 
effectors, regulatory elements, and the nature of the 
cargo delivered to lysosomes [1]. CMA selectively 
degrades soluble cytosolic proteins displaying a 
targeting signature [6], the KFERQ motif, which is 
recognized by a cytosolic chaperone complex that 
facilitates the delivery of substrates to lysosomes [7]. 
The binding of the chaperone-protein substrate complex 
to the lysosome-associated membrane protein (LAMP)-
2A allows unfolding and internalization of the protein 
into  lysosomes for degradation [7].  In  contrast,  micro- 
 
 































autophagy [5], the least studied form of autophagy, 
requires the sequestration of cytoplasmic substrates 
within lysosomal membranes per se that are then 
pinched off to deliver the cargo into the lysosomal 
lumen. Despite these differences, a common theme in 
between all these three autophagic pathways is the 





The orchestration of macroautophagy (henceforth 
autophagy), a complex and tightly regulated process, 
requires more than 30 atg  or autophagy genes as 
elucidated through elegant yeast genetic studies [9, 10]. 
Although autophagy occurs at basal levels in all cells, 
diverse environmental stressors and nutrient deprivation 
are strong inducers of this degradative machinery [1]. A 
key negative regulator of autophagy is the nutrient 
sensor mammalian target of rapamycin (mTOR) [11, 
12]. In presence of nutrients, mTOR inhibits autophagy 
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Atg1 in yeast), Atg13, and focal adhesion kinase family 
interacting protein of 200 kD (FIP200), which form part 
of a complex that initiates autophagy [2, 13, 14]. In 
contrast, the absence of nutrients inhibits mTOR, 
allowing ULK1 to form a complex with Atg13 and 
FIP200 that activates autophagy. Recent studies by a 
number of independent groups have now shown that a 
cellular sensor of energy depletion, AMPK, activates 
autophagy through its ability to phosphorylate and 
activate its recently elucidated downstream substrate 
ULK1 [15-17]. 
 
Briefly, the activation of autophagy in response to 
nutrient deprivation requires the release of Beclin (Atg6 
in yeast) from its binding partner Bcl-2 [18] (Figure 1). 
Beclin is then free to complex with vacuolar protein 
sorting (vps) 34, vps15 and Atg14 to form the active 
class III phosphoinositide 3-kinase (PI3K) complex [19, 
20]. The lipid kinase activity of the class III PI3K 
complex yields phosphatidylinositol 3-phosphate (PI3P) 
that recruits additional Atg proteins to generate the 
































gives rise to the autophagosome [2]. Although there is 
significant debate over the precise cellular locations at 
which autophagosomes are generated, studies now show 
that the plasma membrane [21], endoplasmic reticulum 
[22] or mitochondria [23] may all contribute to de novo 
limiting membrane formation. The elongation of the 
limiting membrane and autophagosome formation 
requires two independent conjugation cascades 
occurring in parallel, the Atg5/12 and the light chain-3 
(LC3, Atg8 in yeast) cascades [24-26], both of which 
require a number of additional Atg proteins including 
the crucial ubiquitin E1-like ligase, Atg7 [27]. In 
addition, the shuttling of Atg9, the exclusive 
transmembrane Atg, to the site of autophagosome 
formation helps provide membranes for the elongation 
of the limiting membrane [28]. The autophagosomes 
then sequester cytoplasmic material destined for 
degradation and deliver these to lysosomes by fusing 
with them where acidic hydrolases serve to breakdown 
cargo. The broken down products, amino acids and fatty 
acids are then reutilized following their efflux in the 
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Although autophagy degrades cellular cargo in an “in-
bulk” manner, this pathway demonstrates significant 
selectivity for the degradation of mitochondria, 
endoplasmic reticulum, ribosomes, and peroxisomes 
through processes termed mitophagy [29], 
reticulophagy [30], ribophagy [31], and pexophagy 
[32], respectively. The recent elucidation of a role for 
autophagy in degrading lipid droplets by lipophagy 
introduced autophagy as a key regulator of cellular lipid 
metabolism [1, 33, 34]. In fact, an acute exposure of 
cultured hepatocytes to distinct lipid stimuli, for 
instance fatty acids or culturing in methionine and 
choline-deficient medium, was sufficient to induce 
autophagy [33]. The induction of autophagy led to the 
breakdown of hepatocellular lipid droplets to increase 
availability of free fatty acids for β-oxidation [33]. The 
genetic or pharmacological inhibition of autophagy 
increased hepatocellular lipid droplet content, as 
determined by fluorescent BODIPY labeling, electron 
microscopic analyses, and by the biochemical 
determination of triglyceride levels [33]. Triglyceride 
accumulation in autophagy-deficient cells did not occur 
from increased synthesis but was a consequence of 
reduced mobilization of lipid droplets. A testament of 
this was the detection of the autophagosome marker 
LC3-II within lipid droplet fractions from livers of 
starved rodents, and that liver-specific deletion of the 
autophagy gene, atg7,  increased lipid droplet number 
and size as revealed by oil red O staining [33].  
 
While acute lipid loading has been shown to activate 
autophagy, chronic lipid exposure such as high fat 
feeding displays an inhibitory effect on autophagy in the 
liver [33] by reducing autophagosome-lysosomal fusion 
[35]. Additionally, lipophagy has now been shown to 
function in a number of diverse cell types such as 
mouse embryonic fibroblasts [33], and in distinct 
neuronal populations, for instance primary 
hypothalamic [36], and striatal neurons [37]. In fact, in 
a recent study in primary striatal neurons [37], 
mutations in huntingtin that impaired recognition of 
cytoplasmic cargo including lipid droplets led to the 
remarkable increase in neuronal lipid accumulation. 
These exciting developments demonstrate that 
autophagic sequestration and lysosomal degradation of 
cellular lipid stores may be a generalized mechanism for 
the mobilization of cytosolic lipid stores [38].  
 
Lipophagy in hypothalamic neurons and energy 
balance 
 
The mediobasal hypothalamus (MBH) consists of 
distinct neuronal populations [39], the agouti-related 
peptide (AgRP) and the proopiomelanocortin (POMC) 
neurons, which form part of a complex neural circuit 
that integrates nutritional, hormonal and neural 
information to regulate food intake and energy 
metabolism [40]. The AgRP neurons secrete orexigenic 
AgRP that increase food intake by serving as a 
physiological antagonist for the melanocortin receptors 
on anorexigenic POMC neurons [41]. In addition, the 
AgRP neurons provide inhibitory γ-aminobutyrate 
(GABA)-ergic projections on to POMC neurons [42]. In 
contrast, POMC neurons express the POMC precursor 
that undergoes significant processing to generate α-
melanocyte stimulating hormone (MSH), which curtails 
appetite and promotes peripheral energy expenditure 
[43].  
 
Although neuronal mechanisms that regulate food 
intake and energy balance are yet unclear, a number of 
candidate signaling molecules have been shown to 
contribute significantly to the control of appetite [44]. 
Studies have demonstrated crucial roles for 
hypothalamic mTOR [45], AMPK [46, 47], PI3K [48, 
49], FoXO1 [50, 51] and insulin signaling cascade in 
the regulation of food intake and energy balance [52, 
53], and intriguingly, all of these signaling pathways 
have been shown to converge upon autophagy [12, 15-
17, 54]. Apart from these pathways, levels of neuronal 
metabolites, such as free fatty acids have also been 
shown to modulate food intake [44]. For instance, 
mitochondrial entry and oxidation of free fatty acids 
regulated via the carnitine palmitoyltransferase (CPT) 
1-dependent pathway has been associated to appetite 
regulation. Activation of central AMPK in response to 
elevated cellular AMP/ATP ratio results in the 
phosphorylation and inactivation of acyl CoA 
carboxylase that, in turn, reduces production of malonyl 
CoA, the allosteric inhibitor of CPT1 [55, 56]. The 
depletion of malonyl CoA removes its allosteric 
inhibition on CPT1 and facilitates mitochondrial fatty 
acid entry, oxidation and increased ATP production 
required for neuronal activation. In fact, findings from a 
recent study suggest that the availability of neuron-
intrinsic free fatty acids and its metabolism may provide 
the bioenergetic requirements for hypothalamic 
neuronal activation and firing [56]. Although neuron-
intrinsic free fatty acids may be necessary for the 
initiation of food-seeking behavior, the mechanisms that 
regulate neuronal availability of free fatty acids are 
unclear.  
 
Since hypothalamic activity of the autophagy regulator, 
mTOR, controls appetite and energy balance [45], and 
given the consideration that hypothalamic neuron-
intrinsic free fatty acids regulate food intake; we asked 
whether induction of autophagy in AgRP neurons 
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acid availability that activated feeding mechanisms. Our 
studies demonstrate that starvation, indeed, induced 
autophagy within the AgRP-expressing hypothalamic 
GT1-7 cells and in the MBH [36]. In parallel with our 
earlier findings in cultured hepatocytes, we observed 
that the provision of an acute lipid stimulus to cultured 
hypothalamic cells markedly increased autophagic flux 
(increased delivery of autophagic substrates to 
lysosomes), and increased protein degradation via the 
lysosomal system [36]. Interestingly, exposure to free 
fatty acids increased hypothalamic levels of 
phosphorylated AMPK and ULK1 [36], which have 
recently been shown to activate autophagy [15-17]. 
These findings raise fundamental questions regarding a 
role for hypothalamic AMPK as part of a neuronal fatty 
acid sensing apparatus that eventually converges upon 
and activates autophagy. Starvation typically increases 
circulating free fatty acids, and thus, we asked whether 
the source of increased hypothalamic lipids during 
starvation is the periphery, as suggested in an earlier 
study [56]. Indeed, culturing hypothalamic cells in 
serum from starved rodents increased neuronal lipid 
accumulation when compared to cells exposed to serum 
from fed rodents. Consistent with these observations 
were the findings of increased fatty acid uptake and 
triglyceride synthesis in hypothalamic cells subjected to 
serum removal, and in MBH explants from food-
restricted mice [36]. Interestingly, the immediate fate of 
free fatty acids taken up by hypothalamic cells was 
triglyceride (TG) synthesis since exposure of starved 
cells to triacsin C, an inhibitor of TG synthesis, 
completely blocked TG synthesis during starvation [36].  
The fact that fatty acids are rapidly esterified to TG 
within lipid droplets underscores the requirement of a 
lipolytic mechanism that breaks down lipid droplets to 
increase availability of cell-intrinsic free fatty acids 
during starvation. Indeed, treatment of cultured 
hypothalamic cells and primary hypothalamic neurons 
to oleic acid increased interactions between auto-
phagosomes/lysosomes and neuronal lipids, demonstrat-
ing that as we observed in liver, hypothalamic 
autophagy functions to deliver neuronal lipid droplets to 
lysosomes [36]. The functional significance of these 
interactions was generation of neuronal free fatty acids, 
since blocking lysosomal degradation or silencing atg5, 
a second autophagy gene, in hypothalamic cells reduced 
cellular free fatty acid levels in response to starvation 
[36]. In addition, the inhibition of lysosomal function 
reduced the increase in AgRP levels that occurred in 
response to fatty acid treatment, following culture in 
fatty acid-enriched starved rodent serum, in response to 
serum deprivation, and even in primary hypothalamic 
neurons cultured under basal conditions [36]. 
Furthermore, inhibiting AgRP neuron-selective auto-
phagy  in vivo reduced MBH AgRP levels and food 
intake specifically in response to fasting [36], although 
no differences in AgRP levels or food intake were 
observed between controls and the autophagy-null mice 
under basal fed conditions. These in vivo findings led us 
to examine the mechanism for reduced adiposity in the 
AgRP neuronal autophagy-deficient rodents. Indeed, 
deleting atg7 in AgRP neurons increased hypothalamic 
levels of the POMC precursor and its cleavage product 
α-MSH that, in turn, reduced body weight and adiposity 
by increasing locomotor activity and upregulating levels 
of the adipose triglyceride lipase in epididymal fat pads 
[36].  
 
Based on these observations, we now provide a 
conceptual framework for considering how induction of 
autophagy during starvation functions to mobilize 
neuronal lipids for the controlled availability of neuron-
intrinsic free fatty acids, which upregulate AgRP levels 
and increase food intake specifically in response to 
starvation (Figure 2) [36].   
 
Aging, autophagy, and future directions 
 
Although our studies reveal a new role for autophagy in 
hypothalamic AgRP neurons in control of food intake 
and energy balance [36], there are several questions that 
will need to be addressed in future studies. For instance, 
is the function of AgRP neuronal autophagy in control 
of food intake limited to lipid mobilization and 
generation of free fatty acids, or are there additional 
roles for autophagy in processes as diverse as actin 
remodeling or regulating cell shape that might be 
crucial for synaptic plasticity, neuron activation and 
firing. While autophagy-regulated free fatty acid 
availability drives expression of AgRP, autophagy 
might also regulate levels of key neuronal proteins 
through controlled lysosomal degradation that may 
modulate appetite and/or energy balance. Additional 
questions directly relevant to the present work include 
mechanisms into how free fatty acids increase AgRP 
levels. Detailed work from Kitamura and colleagues 
highlight roles for FoxO1-dependent mechanisms in 
control of AgRP expression [51], which begs the 
question whether autophagy-derived free fatty acids 
might possibly feed on to these signaling cascades to 
drive AgRP levels during starvation. Additionally, 
neuronal free fatty acids might form secondary lipid 
species that, in turn, may possibly drive PPAR-
dependent transcriptional events within the 
hypothalamus to modulate appetite [57].  
 
Since the AgRP and POMC neuronal network 
coordinate the regulation of food intake, the next 
obvious question pertains to roles for autophagy in the 
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neurons in the MBH positively regulate energy 
expenditure in the periphery, thus it could be 
speculated that reduced autophagy in these neurons 
may contribute to an adiposity phenotype. Indeed, 
unpublished results from our laboratory reveal that 
genetic ablation of autophagy selectively in hypo-
thalamic POMC neuron promotes an early onset 
adiposity and altered glucose homeostasis. 
Additionally, a recent study that blocked hypothalamic 
autophagy using acute lentiviral-mediated silencing of 
atg7 in the MBH has revealed a marked increase in 
adiposity and reduced glucose tolerance in the absence 
of hypothalamic autophagy [58]. These results indicate 
that the predominant effect of blocking autophagy in 
all cell types in the MBH, as would be expected from 
use of this experimental approach, is increased 
adiposity occurring possibly from the masking of the 
beneficial affects observed from the singular targeting 
of autophagy in AgRP neurons [36].  
 
Autophagy is typically considered to decrease with age 

































distribution [61], in addition to affecting food intake 
[62], although marked reduction in food intake is more 
commonly observed in advanced stages due to terminal 
conditions. Thus, it is not surprising that redundant 
central mechanisms may be involved in control of food 
intake that occurs under basal conditions, and that loss 
of one mechanism may allow additional processes to 
compensate, which might explain why appetite per se 
may not decline until very late in life. Elegant work 
from Andrews and colleagues shows that AgRP/NPY 
neurons may be protected against reactive oxygen 
species (ROS) via uncoupling protein (UCP) 2-
dependent mechanisms [56], and these results have led 
to the speculation that progressive POMC neuronal 
damage from higher basal ROS levels observed in these 
neurons may contribute to obesity-related disorders 
observed during aging [56]. In parallel with this line of 
thought, one might postulate that the activity of POMC 
neuronal autophagy may decrease relatively early in the 
aging process, as opposed to autophagy in AgRP 
neurons, which might explain the progressive increases 
in adiposity occurring during middle age, although food 
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pharmacological, have been shown to prevent the 
decline of autophagy observed during aging. Calorie 
restriction is a strong inducer of autophagy, and has 
been shown to promote lifespan extension in a number 
of species [63-65]. In fact, Caenorhabditis elegans 
lacking autophagy genes did not display extended 
longevity in response to caloric restriction [66, 67]. 
Calorie restriction also delayed the incidence of 
diabetes, cancer, cardiovascular disease and brain 
atrophy, as well as mortality in primates [68], although 
it was not shown whether these effects in primates were 
mediated through upregulation of autophagy. Although 
benefits of calorie restriction are thought to be exerted, 
at least in part, via reduction of visceral adiposity [69, 
70], it would be immensely interesting to test whether 
calorie restriction may restore some of these peripheral 
metabolic defects through direct effects on autophagy in 
the central nervous system. Restricting nutrients 
downregulate mTOR, and hyperactive mTOR has been 
demonstrated to bring about a number of ill effects 
associated with the aging process, for instance 
generation of cellular senescence in vitro [71-73], 
dysregulated protein synthesis and its effects on 
proteotoxicity [74], as well as reducing insulin 
sensitivity through S6K1-mediated degradation of 
IRS1/2 [75]; therefore favorable effects of calorie 
restriction may be attributed to both reduced mTOR 
activity and/or improved cellular quality control via the 
upregulation of autophagy [76, 77]. Pharmacological 
interventions that upregulate autophagy, such as use of 
rapamycin that inhibits the negative regulator of 
autophagy, mTOR, have been shown to confer 
longevity in yeast [78], worms [66], and in aged 
heterogeneous mice [79]. Additional pharmacological 
agents, in particular spermidine [80], have been shown 
to mediate lifespan extension through the upregulation 
of autophagy [81]. Although, these agents may have 
contributed to lifespan extension through upregulation 
of autophagy in peripheral tissues, it may be expected 
that pharmacological upregulation of autophagy in the 
central nervous system using one or more of these 
agents will protect against adiposity and reduced insulin 
sensitivity in peripheral tissues observed during aging.  
  
Indeed, if there is a case for restoration of autophagy 
during aging, then the question that needs to be 
addressed first is what might be the mechanism for 
reduced autophagy during aging? We [33], and others 
[35, 82] have shown that prolonged high fat feeding 
inhibits autophagy in the liver, which then sets up a 
vicious circle that furthers lipid accumulation. Aging is 
typically associated with lipid accumulation, and 
although the dynamics and consequences of lipid 
accumulation during aging may be quite distinct from 
those observed with high fat feeding, it is possible that 
aging-induced chronic lipid build up in neurons may 
dysregulate autophagy and energetic balance through 
one of many effects including generation of reactive 
oxygen species, changes in membrane lipid composition 
and function, and hyperactivation of key upstream 
regulators, for instance mTOR. A recent study 
highlights a highly complex neuroendocrine modulation 
of autophagy by the adiposity hormone leptin, 
suggesting the presence of yet uncovered links between 
adiposity hormones, autophagy, the biology of aging, 
peripheral insulin signaling and energy balance [83]. 
Moreover, the functional consequences of reduced 
autophagy in nutrient sensing neurons need to be fully 
characterized. The further characterization of roles for 
autophagy in distinct neuronal subsets, as well as 
mechanistic insights into how autophagy modulates 
neuron function to affect whole body energetic balance 
may have implications for development of novel 
therapeutic strategies in the fight against obesity and 
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